TCI Wealth Advisors’s VanEck Biotech ETF BBH Stock Holding History

TCI Wealth Advisors’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-80	Closed	-$9K	–	887
2014 Q4	$9K	Buy	+80	New	+$9.02K	0.01%	463

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

TCI Wealth Advisors's BBH Position: Q1 2015 in Review

TCI Wealth Advisors sold out of VanEck Biotech ETF (BBH) in Q1 2015, closing a stake of 80 shares — an estimated $9K sold.

TCI Wealth Advisors first reported a position in BBH in Q4 2014 and held it in 1 quarter. The position peaked at $9K in Q4 2014. 78 funds tracked by Wall St. Rank hold BBH as of Q1 2015.

TCI Wealth Advisors reported no remaining VanEck Biotech ETF position as of Q1 2015 after selling out during the quarter.
TCI Wealth Advisors sold 80 VanEck Biotech ETF shares in Q1 2015, an estimated $9K.
TCI Wealth Advisors first reported a position in VanEck Biotech ETF in Q4 2014 and held it in 1 quarter.
TCI Wealth Advisors's VanEck Biotech ETF position peaked at $9K in Q4 2014.
78 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2015.

Based on TCI Wealth Advisors's 13F filing for Q1 2015, filed 30 Apr 2015.